CHD

Business profile & competitive position

Church & Dwight Co., Inc. is a Consumer Defensive company in the Household & Personal Products industry. It develops, manufactures, and markets consumer household and personal care products, plus specialty products focused on animal nutrition, specialty chemicals, and commercial/professional cleaners. Its recognizable brands include ARM & HAMMER, OXICLEAN, BATISTE, WATERPIK, THERABREATH, HERO, TOUCHLAND, TROJAN, FIRST RESPONSE, NAIR, ORAJEL, XTRA, and ZICAM. Operations are organized into three segments: Consumer Domestic, Consumer International, and Specialty Products Division.

The numbers support the idea that CHD’s edge comes from repeat-purchase brand equity rather than low-cost manufacturing dominance. Net margin is 12.0%, which is healthy for packaged consumer goods but not extraordinary, while ROE is 17.8%—well above what most capital-intensive businesses produce. The stock’s beta of 0.47 also signals that revenue and cash flow are relatively insulated from broad equity volatility, consistent with a portfolio of everyday essentials.

Financial posture

Church & Dwight carries a market capitalization of $23.4B and trades at a trailing P/E of 31.6. That multiple sits at a premium to many diversified consumer staples names, implying the market is pricing in above-average earnings stability and brand-derived cash flow. The 12.0% net margin and 17.8% ROE help explain the valuation gap: the company converts sales into shareholder returns at a rate that justifies a higher-than-average multiple, at least on a trailing basis.

The beta of 0.47 is another defining feature. For every 1% swing in the broader market, CHD historically moves less than half as much. Combined with its sector classification and household-product focus, this points to a company generally treated as a defensive holding, though the 31.6 P/E also means expectations are already elevated compared with slower-growth staples peers.

Strategic priorities & outlook

Church & Dwight’s most recent 10-K filing outlines a clear set of near-term priorities. The company is repositioning the portfolio to concentrate on faster-growing value and premium product lines, a shift that follows the exits of Flawless, Spinbrush, the Waterpik showerhead line, and the VMS brands. It is also integrating the Touchland hand-sanitizer acquisition and trying to realize that deal’s intended impact on sales and earnings.

Global expansion of the seven “power brands” is a third priority. Those seven brands represented approximately 70% of consolidated net sales and profits in 2025, so their growth trajectory is the dominant driver of overall performance. Operationally, CHD continues building supply-chain resilience by maintaining qualified dual sources for roughly 70% of direct materials spend.

One customer concentration risk is explicit in the filing: Walmart accounted for about 23% of consolidated net sales in 2025, and no other customer exceeded 10% over the past three years. Within Consumer Domestic, household products represented approximately 54% of segment net sales and personal care represented approximately 46% in 2025.

Macro & geopolitical exposure

As a Household & Personal Products business, CHD is exposed to the macro variables that shape consumer staples more broadly. Demand for its products is relatively resilient in slowdowns, but it is not immune to input-cost inflation in resins, chemicals, packaging, and transportation. Freight rates and supplier disruptions can pressure margins, while foreign-exchange swings affect the Consumer International segment because overseas revenue is translated back into U.S. dollars.

Trade policy matters here as well: tariffs on imported raw materials or finished goods can raise costs, and retaliatory duties can limit growth in foreign markets. Regulation is another real factor. Personal care, oral care, OTC health products, contraceptives, and medical devices such as WATERPIK fall under FDA, FTC, and other consumer-health oversight. Labeling, advertising, safety, and manufacturing standards all carry compliance risk in this sector.

Recent developments

Recent headlines reflect both institutional positioning and broader sector interest. On 2026-08-31, 247wallst.com included CHD in “4 Battle-Tested Consumer Staples Stocks That Keep Raising Their Dividends,” and invezz.com reported that BofA named Church & Dwight among “3 stocks with meaningful upside in September.” On the same day, defenseworld.net reported that Corient Private Wealth LP had made a new investment in CHD. The following day, 2026-09-01, defenseworld.net noted that Beacon Pointe Advisors LLC had invested $742,000 in the stock.

None of these items are operational updates, but together they show that portfolio managers and wealth advisors were adding or highlighting the name heading into late summer 2026.

Earnings behavior & post-earnings drift

Over the last eight reported quarters, CHD has beaten the official consensus six times, for a 86% beat rate, with an average earnings surprise of 5.2%. The average 5-day price move in the trading sessions after those reports was 1.32%, classified as an upward drift. That headline profile looks strong, but the actual quarter-by-quarter path undercuts the simple “beat means pop” assumption.

In the most recent report, dated 2026-07-31, CHD posted actual EPS of $0.89 versus an estimate of $0.896, a -0.7% miss. The stock nevertheless rose 1.21% the next day and 4.48% over the following five sessions. The prior quarter, 2026-05-01, was a beat: actual EPS of $0.95 against $0.931 estimated, a 2.0% positive surprise, yet the stock fell 3.26% the next day and 2.69% over five days.

Going back further, the 2026-01-30 report delivered a 2.9% beat ($0.86 actual versus $0.836 estimate) and produced a 1.13% next-day gain and a 4.45% five-day gain. But the 2025-10-31 report showed a 10.1% beat ($0.81 actual versus $0.736 estimate) and the stock still fell 1.61% the next day and 0.95% over the next five sessions.

The takeaway is that the post-earnings reaction has not reliably followed the direction of the surprise. The next scheduled report is 2026-10-30 before the market opens, with a consensus EPS estimate of $0.90. As of the latest snapshot, CHD traded at $98.55, with an RSI of 43.9 and a 50-day EMA of $99.35.

For readers who want to go deeper than the raw numbers, the next logical step is to dig into the full institutional verdict on Church & Dwight, including sell-side ratings, estimate revision trends, and peer valuation comparisons. This analysis is educational only and does not constitute a recommendation to buy, sell, or hold the stock.